Literature DB >> 1649077

Ferritin, lipid peroxidation and redox-cycling xenobiotics.

C C Winterbourn1, G F Vile, H P Monteiro.   

Abstract

A number of xenobiotics are toxic because they redox cycle and generate free radicals. Interaction with iron, either to produce reactive species such as the hydroxyl radical, or to promote lipid peroxidation, is an important factor in this toxicity. A potential biological source of iron is ferritin. The cytotoxic pyrimidines, dialuric acid, divicine and isouramil, readily release iron from ferritin and promote ferritin-dependent lipid peroxidation. Superoxide dismutase and GSH, which maintain the pyrimidines in their reduced form, enhance both iron release and lipid peroxidation. Microsomes plus NADPH can reduce a number of iron complexes, although not ferritin. Reduction of Adriamycin, paraquat or various quinones to their radicals by the microsomes enhances reduction of the iron complexes, and in some cases, enables iron release from ferritin. Adriamycin stimulates iron-dependent lipid peroxidation of the microsomes. Ferritin can provide the iron, and peroxidation is most pronounced at low pO2. Complexing agents that suppress intracellular iron reduction and lipid peroxidation may protect against the toxicity of Adriamycin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649077     DOI: 10.3109/10715769109145774

Source DB:  PubMed          Journal:  Free Radic Res Commun        ISSN: 8755-0199


  9 in total

1.  The transcriptional activation of the human copper/zinc superoxide dismutase gene by 2,3,7,8-tetrachlorodibenzo-p-dioxin through two different regulator sites, the antioxidant responsive element and xenobiotic responsive element.

Authors:  Eun Young Park; Hyune Mo Rho
Journal:  Mol Cell Biochem       Date:  2002-11       Impact factor: 3.396

2.  Stability of adriamycin-induced DNA adducts and interstrand crosslinks.

Authors:  A van Rosmalen; C Cullinane; S M Cutts; D R Phillips
Journal:  Nucleic Acids Res       Date:  1995-01-11       Impact factor: 16.971

3.  Changes in antioxidative activities induced by Fe (II) and Fe (III) in cultured Vero cells.

Authors:  C García-Alfonso; J López-Barea; P Sanz; G Repetto; M Repetto
Journal:  Arch Environ Contam Toxicol       Date:  1996-05       Impact factor: 2.804

4.  Detection of adriamycin-induced cardiotoxicity in cultured heart cells with technetium 99m-SESTAMIBI.

Authors:  D Piwnica-Worms; M L Chiu; J F Kronauge
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

5.  Lipid peroxidation products, and vitamin and trace element status in patients with cancer before and after chemotherapy, including adriamycin. A preliminary study.

Authors:  M Faber; C Coudray; H Hida; M Mousseau; A Favier
Journal:  Biol Trace Elem Res       Date:  1995 Jan-Mar       Impact factor: 3.738

6.  Effect of antioxidants on adriamycin-induced microsomal lipid peroxidation.

Authors:  H Hida; C Coudray; J Calop; A Favier
Journal:  Biol Trace Elem Res       Date:  1995 Jan-Mar       Impact factor: 3.738

Review 7.  Oxidative stress in aging human skin.

Authors:  Mark Rinnerthaler; Johannes Bischof; Maria Karolin Streubel; Andrea Trost; Klaus Richter
Journal:  Biomolecules       Date:  2015-04-21

8.  Desferrioxamine decreases NAD redox potential of intact red blood cells: evidence for desferrioxamine as an inducer of oxidant stress in red blood cells.

Authors:  Yutaka Niihara; Junli Ge; Oded Shalev; Huiyuan Wu; Amy Tu; Kouichi R Tanaka
Journal:  BMC Clin Pharmacol       Date:  2002-10-24

Review 9.  Role of Drug Metabolism in the Cytotoxicity and Clinical Efficacy of Anthracyclines.

Authors:  Derek W Edwardson; Rashmi Narendrula; Simon Chewchuk; Kyle Mispel-Beyer; Jonathan P J Mapletoft; Amadeo M Parissenti
Journal:  Curr Drug Metab       Date:  2015       Impact factor: 3.731

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.